NCT03047395 A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) Status COMPLETED Phase PHASE3
NCT03035279 A Study of SC-006 and in Combination With ABBV-181 in Subjects With Advanced Colorectal Cancer Status TERMINATED Phase PHASE1
NCT03033511 A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) Status TERMINATED Phase PHASE3
NCT03033498 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease Status COMPLETED Phase PHASE1
NCT03026166 A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03022045 A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis Status COMPLETED Phase PHASE3
NCT03017014 A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions Status TERMINATED Phase N/A
NCT03006068 A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03003338 MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV Status TERMINATED Phase PHASE4
NCT03002818 Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®) Status COMPLETED Phase N/A
NCT03001115 Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects Status COMPLETED Phase N/A
NCT03000257 A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03000075 BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02993523 A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02988960 A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02988674 A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation Status COMPLETED Phase N/A
NCT02986373 A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171) Status COMPLETED Phase PHASE2